Jeong P - Search Results

1

Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.

Kwak SH, Lim WY, Hao A, Mashalidis EH, Kwon DY, Jeong P, Kim MJ, Lee SY, Hong J. Kwak SH, et al. Among authors: jeong p. Eur J Med Chem. 2021 Apr 5;215:113272. doi: 10.1016/j.ejmech.2021.113272. Epub 2021 Feb 6. Eur J Med Chem. 2021. PMID: 33607457 Free PMC article.

2

Methotrexate recognition by the human reduced folate carrier SLC19A1.

Wright NJ, Fedor JG, Zhang H, Jeong P, Suo Y, Yoo J, Hong J, Im W, Lee SY. Wright NJ, et al. Among authors: jeong p. Nature. 2022 Sep;609(7929):1056-1062. doi: 10.1038/s41586-022-05168-0. Epub 2022 Sep 7. Nature. 2022. PMID: 36071163 Free PMC article.

3

Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia.

Jeong P, Moon Y, Lee JH, Lee SD, Park J, Lee J, Kim J, Lee HJ, Kim NY, Choi J, Heo JD, Shin JE, Park HW, Kim YG, Han SY, Kim YC. Jeong P, et al. Eur J Med Chem. 2020 Jun 1;195:112205. doi: 10.1016/j.ejmech.2020.112205. Epub 2020 Mar 6. Eur J Med Chem. 2020. PMID: 32272419

4

Novel Thioxothiazolo[3,4-a]quinazolin-5(4H)-one Derivatives as BK_Ca Channel Activators for Urinary Incontinence.

Bae EJ, Jo H, Kim SS, Shin DS, Yang JY, Bae MA, Jeong P, Park CS, Ahn JH. Bae EJ, et al. Among authors: jeong p. ACS Med Chem Lett. 2022 Jun 21;13(7):1052-1061. doi: 10.1021/acsmedchemlett.2c00070. eCollection 2022 Jul 14. ACS Med Chem Lett. 2022. PMID: 35859863 Free PMC article.

5

Synthesis and structure-activity relationship studies of 1,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 1 (JAK1) inhibitors.

Kim W, Lee SM, Jeong PH, Jung JH, Kim YC. Kim W, et al. Bioorg Med Chem Lett. 2022 Jan 1;55:128451. doi: 10.1016/j.bmcl.2021.128451. Epub 2021 Nov 11. Bioorg Med Chem Lett. 2022. PMID: 34774741

6

Discovery of indirubin-3'-aminooxy-acetamide derivatives as potent and selective FLT3/D835Y mutant kinase inhibitors for acute myeloid leukemia.

Lee JH, Shin JE, Kim W, Jeong P, Kim MJ, Oh SJ, Lee HJ, Park HW, Han SY, Kim YC. Lee JH, et al. Among authors: jeong p. Eur J Med Chem. 2022 Jul 5;237:114356. doi: 10.1016/j.ejmech.2022.114356. Epub 2022 Apr 21. Eur J Med Chem. 2022. PMID: 35489222

7

Discovery of benzimidazole-indazole derivatives as potent FLT3-tyrosine kinase domain mutant kinase inhibitors for acute myeloid leukemia.

Ko B, Jang Y, Kim MH, Lam TT, Seo HK, Jeong P, Choi M, Kang KW, Lee SD, Park JH, Kim M, Han SY, Kim YC. Ko B, et al. Among authors: jeong p. Eur J Med Chem. 2023 Dec 15;262:115860. doi: 10.1016/j.ejmech.2023.115860. Epub 2023 Oct 7. Eur J Med Chem. 2023. PMID: 37866334

8

Discovery and structure-activity relationships of pyrazolodiazepine derivatives as the first small molecule agonists of the Drosophila sex peptide receptor.

Kim JH, Jeong PH, Lee JY, Lee JH, Kim YJ, Kim YC. Kim JH, et al. Bioorg Med Chem. 2015 Apr 15;23(8):1808-16. doi: 10.1016/j.bmc.2015.02.035. Epub 2015 Feb 24. Bioorg Med Chem. 2015. PMID: 25797164

9

Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents.

Kim W, Kang JA, Park M, Jeong PH, Kim YJ, Cho Y, Park SG, Kim YC. Kim W, et al. J Med Chem. 2021 May 13;64(9):5500-5518. doi: 10.1021/acs.jmedchem.0c01938. Epub 2021 Apr 22. J Med Chem. 2021. PMID: 33887912

10

Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy.

You H, Yoon HE, Jeong PH, Ko H, Yoon JH, Kim YC. You H, et al. Bioorg Med Chem. 2015 Apr 1;23(7):1453-62. doi: 10.1016/j.bmc.2015.02.014. Epub 2015 Feb 16. Bioorg Med Chem. 2015. PMID: 25753328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters